NEW YORK (AP) ¿ Biotechnology company Enzo Biochem Inc. said Thursday its 2010 fiscal first-quarter loss narrowed on a boost in laboratory services and product revenue.

The company provides diagnostic services and makes research products and medical tools.

For the three months ended Oct. 31, the company lost $1.8 million, or 5 cents per share, compared with a loss of $6.4 million, or 17 cents per share, a year ago. Revenue rose 19 percent to $25.2 million from $21.1 million.

Revenue from tests and other products rose 8 percent during the quarter to $10.7 million while clinical lab services revenue climbed 36 percent to $11.1 million. Royalties and license fee income increased 14 percent to $3.3 million.

Enzo shares fell 18 cents, or 3.2 percent, to close at $5.38.
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

If you liked this article you might like

What's Behind the Surge in Energy Stocks

Hillary Clinton Says Prosecuting Individuals is Key to Wall Street Reform